Home |
Prof.Süssmuth |
People |
Research |
Publications |
Equipment |
Teaching |
RTG2473/1 |
Contact/Jobs |
Albicidin |
Feglymycin |
Class
II Lanthipeptides |
Class
III Lanthipeptides |
CDPs |
Paenilamicin |
Abyssomicin |
Salmochelin |
Skyllamycin |
MembraTech |
Coworkers: Dr. Agnes Mühlenweg, Annette Poch
Keywords: polyketides, PKS, p-aminobenzoate/folate biosynthesis inhibitor, tetronic acid
Cooperation: Prof. Hans-Peter Fiedler, University of Tübingen, Prof. Peter Leadley, Cambridge University, UK
Polyketides are a group of secondary metabolites and serve as potent antiinfectives. Abyssomicins constitute an important subgroup of polyketides, which are characterized by an oxabicyclooctane system and a tetronic acid unit. These products were identified and isolated in cooperation with the Fiedler group in Tübingen in the context of a biological screening for inhibitors of p-aminobenzoate (pABA) in Verrucosispora maris AB-18-032. The
organism produces different types of Abyssomicins based on
the biosynthesis of linear polyketide precursors. The most
famous example of the Abyssomicins is Abyssomicin C. We
could show, that atrop-Abyssomicin C is
the main product, while Abyssomicin C occurs as a more
stable but less active artifact during purification. Atrop-Abyssomicin C and
Abyssomicin C are potent against a variety of Gram-positive
bacteria including pathogenic and drug resistant strains
like MRSA. Studies related to the mode of action revealed
them as covalent inhibitors of PabB and therefore as potent
inhibitors of the biosynthesis of folic acid in
microorganisms. Due to this fact Abyssomicin
C and derivatives seem to be very potential drug candidates
to overcome the gap of new antibiotics and the growing
resistance problem. The formation of the tetronic acid unit and the evolutionary relation of biosynthetic gene clusters of different Abyssomicin producers are subject to investigations. Currently, various Abyssomicin producing strains are investigated and compared to each other to elucidate the underlying biosynthetic mechansims. Furthermore combinatorial biosynthesis approaches could enable the generation of novel Abyssomicin derivatives. |
Figure 1. Structures of Abyssomicins C (1a), B (2), D (4), G (5), H (5) and atrop-Abyssomicin C (1b). |